COVID-19 Pregnancy Related Immunological, Clinical and Epidemiological Factors and Perinatal Outcomes

NCT04659759 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 105

Last updated 2025-12-02

No results posted yet for this study

Summary

This is a prospective cohort study of pregnant patients at an urban academic center diagnosed with perinatal COVID-19 infection, followed up to 6 weeks postpartum.

Conditions

  • Covid19

Interventions

OTHER

COVID-19 exposure

COVID-19 exposure during pregnancy

BIOLOGICAL

COVID-19 vaccine

Receipt of any COVID-19 vaccine

Sponsors & Collaborators

  • Nemours

    collaborator UNKNOWN
  • Thomas Jefferson University

    lead OTHER

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-17
Primary Completion
2025-08-30
Completion
2025-08-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04659759 on ClinicalTrials.gov